Skip to main content
Account

Peer review reports

From: An open label, randomised controlled trial of rifapentine versus rifampicin based short course regimens for the treatment of latent tuberculosis in England: the HALT LTBI pilot study

Original Submission
15 Oct 2020 Submitted Original manuscript
26 Oct 2020 Author responded Author comments - Julian Surey
Resubmission - Version 2
26 Oct 2020 Submitted Manuscript version 2
21 Nov 2020 Reviewed Reviewer Report
22 Nov 2020 Reviewed Reviewer Report
14 Dec 2020 Author responded Author comments - Julian Surey
Resubmission - Version 3
14 Dec 2020 Submitted Manuscript version 3
4 Jan 2021 Author responded Author comments - Julian Surey
Resubmission - Version 4
4 Jan 2021 Submitted Manuscript version 4
Publishing
5 Jan 2021 Editorially accepted
21 Jan 2021 Article published 10.1186/s12879-021-05766-9

Learn about peer review

Back to article page

Navigation